Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | RARB | P10826 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | RAD52 | P43351 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14674414 | 1.00 | NAAA (0.43) | NAAARARBNPSR1MAPTMAPK1 | |
| SCHEMBL14673679 | 1.00 | NAAA (0.43) | NAAARARBNPSR1MAPTMAPK1 | |
| SCHEMBL29929707 | 1.00 | NAAA (0.43) | NAAARARBNPSR1MAPTMAPK1 | |
| SCHEMBL15698 | 1.00 | NAAA (0.43) | NAAARARBNPSR1MAPTMAPK1 | |
| SCHEMBL21409612 | 1.00 | NAAA (0.43) | NAAARARBNPSR1MAPTMAPK1 | |
| SCHEMBL31648000 | 0.94 | DGKA (0.42) | NAAAMAPTL3MBTL1HTR2C | |
| SCHEMBL29586311 | 0.90 | NAAA (0.36) | NAAARARBNPSR1MAPTMAPK1 | |
| SCHEMBL28299537 | 0.89 | DGKA (0.53) | NAAAMAPTHTR2C | |
| SCHEMBL27578268 | 0.88 | GPR84 (0.42) | NAAARARBHTT | |
| SCHEMBL7134598 | 0.87 | NAAA (0.44) | NAAANPSR1MAPTMAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115536908-B | Preparation method and application of polyester-based environment-friendly plasticizer constructed by biomass acid combination | 江南大学 | 2023-06-13 | — | — | CN | claimed |
| CN-115536908-A | Preparation method and application of polyester-based environment-friendly plasticizer constructed by combining biological hyaluronic acid | 江南大学 | 2022-12-30 | — | — | CN | claimed |
| US-20100172851-A1 | Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites | YU RUEY J | 2010-07-08 | — | — | US | claimed |
| CN-115038753-B | Composition, curable composition, cured product, and storage method | 株式会社钟化 | 2024-03-19 | — | — | CN | disclosed |
| US-20230250325-A1 | Urethane Adhesive Composition | SIKA TECHNOLOGY AG (CH) | 2023-08-10 | — | — | US | disclosed |
| CN-115536908-B | Preparation method and application of polyester-based environment-friendly plasticizer constructed by biomass acid combination | 江南大学 | 2023-06-13 | — | — | CN | disclosed |
| CN-115536908-B | Preparation method and application of polyester-based environment-friendly plasticizer constructed by biomass acid combination | 江南大学 | 2023-06-13 | — | — | CN | disclosed |
| EP-4169996-A1 | URETHANE ADHESIVE COMPOSITION | Sika Hamatite Co., Ltd. (JP) | 2023-04-26 | — | — | EP | disclosed |
| WO-2023048155-A1 | ONE-PACK TYPE CURABLE COMPOSITION AND CURED PRODUCT | 株式会社カネカ | 2023-03-30 | — | — | WO | disclosed |
| CN-115536908-A | Preparation method and application of polyester-based environment-friendly plasticizer constructed by combining biological hyaluronic acid | 江南大学 | 2022-12-30 | — | — | CN | disclosed |
| CN-115536908-A | Preparation method and application of polyester-based environment-friendly plasticizer constructed by combining biological hyaluronic acid | 江南大学 | 2022-12-30 | — | — | CN | disclosed |
| US-8709978-B2 | Herbicide composition having improved effectiveness, method of preparation and use | AGRO INDUSTRIE RECHERCHES ET DEVELOPPEMENTS (A.R.D.) (FR) | 2014-04-29 | — | — | US | disclosed |
| US-20130035234-A1 | HERBICIDE COMPOSITION HAVING IMPROVED EFFECTIVENESS, METHOD OF PREPARATION AND USE | AGRO INDUSTRIE RECHERCHES ET DEVELOPPEMENTS (A.R.D.) (FR) | 2013-02-07 | — | — | US | disclosed |
| US-20100172851-A1 | Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites | YU RUEY J | 2010-07-08 | — | — | US | disclosed |
| US-7709014-B2 | Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites | YU RUEY J | 2010-05-04 | — | — | US | disclosed |
| CN-101330911-A | Hydroxy-polycarboxylic acid esters: action on nerves and use on skin and mucocutaneous organs or sites | SCOTT EUGENE J VAN (US) | 2008-12-24 | — | — | CN | disclosed |
| EP-1937246-A2 | HYDROXY-OLIGOCARBOXYLIC ESTERS: EFFECTS ON NERVE AND USE FOR CUTANEOUS AND MUCOCUTANEOUS ORGANS OR SITES | Yu, Ruey J., Dr. (US) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007047486-A2 | HYDROXY-OLIGOCARBOXYLIC ESTERS: EFFECTS ON NERVE AND USE FOR CUTANEOUS AND MUCOCUTANEOUS ORGANS OR SITES | YU RUEY J (US) | 2007-04-26 | — | — | WO | disclosed |
| US-20070093551-A1 | Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites | YU RUEY J | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035234-A1 | HERBICIDE COMPOSITION HAVING IMPROVED EFFECTIVENESS, METHOD OF PREPARATION AND USE | DDT, HDHD5, PAOX | NAAA 47/4885RARB 1131/4885NPSR1 2443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.